Sign in
4/A

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-08-015120

Chief Financial Officer acquired 44,795 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2008-06-12 Exercise or conversion : show line 1 in the form +44,795 $1.10 $49,275 260,376 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2008-06-12 Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) −44,795 $1.10 2014-02-25 44,795 189,624 D
Loading xslF345X02/doc1.xml…